序贯疗法根除幽门螺杆菌的临床研究

目的 观察由奥美拉唑、阿莫西林、克拉霉素、呋喃唑酮组成的10d序贯疗法根除幽门螺杆菌（Hp）的疗效,并与传统三联疗法进行比较.方法 选择Hp阳性的消化性溃疡、慢性胃炎伴胃黏膜萎缩或糜烂的成人患者155例,随机分为两组,试验组：在前5 d的诱导期中应用奥美拉唑联合阿莫西林口服,在后5 d中应用奥美拉唑,克拉霉素、呋喃唑酮口服治疗.对照组：奥美拉唑,联合阿莫西林、克拉霉素口服治疗7d.结果 治疗组Hp根除率为92.31%,对照组Hp根除率为72.73%,两组比较差异有统计学意义（P〈0.01）.结论由奥美拉唑、阿莫西林、克拉霉索、呋喃唑酮组成的10 d序贯疗法治疗Hp感染具有根除率高、安全、和依从性好等优点.

Clinical research of sequential therapy for Helicobacter pylori-infected patient

Objective To observe the efficacy for the eradication of Helicobacter pylori (Hp) by using the 10-day sequential therapy consisting of omeprazle,amoxicillin,clarithromycin,and furazolidone,and to compare with the traditional triple-drug therapy.Methods 155 adult patients,who were Hp positive with peptic ulcer,chronic gastritis with mucosal atrophy or erosion,were selected and randomly divided into two groups.The patients in 10-day sequential therapy group received omeprazole and amoxicillin in the first 5 days followed by another 5 days of ome-prazole,clarithromycin and furazolidone.The patients in traditional triple-drug therapy group recieved omeprazole,amoxicillin,and clarithromycin for 7 days.Results The HP eradication rate of the 10-day sequential therapy group was 92.31% ,while the traditional triple-drug group was 72.73%.The difference between the two groups was statistically significant (P<0.01).Conclusion The 10-day sequential therapy consisting of omeprazole,amoxicillin,clarithromycin and furazolidone achieved higher eradication rate,and it was safe,and good compliance.